Sherritt Provides Notice of First Quarter 2025 Results Conference Call
Dial-in and Webcast Details:
Please dial in 15 minutes before the start of the conference to secure a line and avoid delays. Alternatively, listeners will be able to access the conference call via the webcast available on Sherritt's website.
A copy of the webcast and replay of the conference call will be available on the website following the presentation.
About Sherritt
Sherritt is a world leader in using hydrometallurgical processes to mine and refine nickel and cobalt – metals deemed critical for the energy transition. Sherritt's Moa Joint Venture has an estimated mine life of approximately 25 years and is advancing an expansion program focused on increasing annual MSP production by 20% of contained nickel and cobalt. The Corporation's Power division, through its ownership in Energas, is the largest independent energy producer in Cuba with installed electrical generating capacity of 506 MW, representing approximately 10% of the national electrical generating capacity in Cuba. The Energas facilities are comprised of two combined cycle plants that produce low-cost electricity from one of the lowest carbon emitting sources of power in Cuba. Sherritt's common shares are listed on the Toronto Stock Exchange under the symbol 'S'.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
an hour ago
- Toronto Star
Rakovina Therapeutics Highlights Long-Standing Collaboration with the University of British Columbia and the Vancouver Prostate Centre
VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. ('Rakovina' or the 'Company') (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered drug discovery, is pleased to highlight its long-standing collaboration with the University of British Columbia (UBC) and its affiliated Vancouver Prostate Centre (VPC), one of Canada's leading cancer research institutions. Rakovina's collaboration with the Vancouver Prostate Centre and UBC ensures that compound testing and validation are conducted within one of the world's most respected cancer facilities. This agreement with UBC enables close collaboration with leading cancer scientists using UBC's state-of-the-art lab infrastructure, both accelerating and de-risking the translation of scientific discovery.
Cision Canada
7 hours ago
- Cision Canada
Dye & Durham Initiates Review of Strategic Alternatives
TORONTO, July 29, 2025 /CNW/ - Dye & Durham Limited ("Dye & Durham" or the "Company") (TSX: DND), a leading provider of cloud-based legal practice management software, today announced that its Board of Directors (the "Board") has initiated a review of strategic alternatives to maximize value for all shareholders. The review may include a sale of the Company, asset sales, recapitalizations or potential mergers. The Company does not intend to make any further public comment regarding the strategic review until it has been completed. In connection with this announcement, the Company has entered into a Cooperation Agreement ("Agreement") with Plantro Ltd. ("Plantro") under which Plantro has agreed to withdraw its special meeting requisition. As part of this agreement, David Danziger, CPA, CA will be appointed to the Board forthwith. Mr. Danziger will also join and serve as Chair of a newly formed Special Committee tasked with leading the strategic review. The Agreement also contains customary standstill provisions and voting commitments. "Over the past several weeks, the Board has engaged with shareholders to carefully consider Dye & Durham's next steps," said Board Chair Arnaud Ajdler. "We appreciate the constructive and pragmatic engagement that we have had with Plantro and Matt Proud toward our shared goal of enhancing value for the Company's shareholders, and we are pleased to have reached a resolution. We welcome David, whose M&A and accounting expertise and significant public company director experience will be incredibly additive." "As one of the Company's largest and longest-standing shareholders, we are pleased to have reached a constructive agreement with the Board that provides the basis to thoughtfully pursue a sale of the Company to preserve and maximize value for all shareholders," said Matt Proud, spokesperson for Plantro. "Plantro is appreciative of the efforts of the Board Chair Arnaud Ajdler in developing this collaborative framework. We look forward to remaining an engaged and constructive shareholder." David Danziger, CPA, CA Biography David Danziger, CPA, CA, is an experienced finance leader and corporate director with an extensive background in audit, accounting, M&A and management consulting. Previously, he was the Senior Vice President, Assurance, and the National Leader of Public Companies at MNP LLP, Canada's fifth-largest accounting firm. Mr. Danziger continues to serve as a Senior Advisor for MNP LLP working on special projects and supporting the Public Company Audit Team nationally. Mr. Danziger has served as a director for a range of technology, mining and life sciences companies listed on the TSX, TSXV, CSE and NYSE. About Dye & Durham Limited Dye & Durham Limited provides premier practice management solutions empowering legal professionals every day, delivers vital data insights to support critical corporate transactions and enables the essential payments infrastructure trusted by government and financial institutions. The company has operations in Canada, the United Kingdom, Ireland, Australia, and South Africa. Additional information can be found at Forward-Looking Statements This press release may contain forward-looking information within the meaning of applicable securities laws, which reflects Dye & Durham's current expectations regarding future events. In some cases, but not necessarily in all cases, forward-looking statements can be identified by the use of forward looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "appears", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In particular, statements regarding the review of strategic alternatives, and the potential sale of the Company, divestiture of assets, recapitalization or merger transactions, and the Company's efforts to maximize value for all shareholders are forward-looking statements. Forward-looking statements are not historical facts, nor guarantees or assurances of future performance but instead represent management's current beliefs, expectations, estimates and projections regarding future events and operating performance. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond Dye & Durham's control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to, the outcome of the strategic review process, the ability to successfully enter into a transaction with a third party relating to the Company, including a potential sale, divesture of assets, recapitalization or merger transaction, and the factors discussed under "Risk Factors" in Dye & Durham's most recent annual information form. Dye & Durham does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Toronto Star
9 hours ago
- Toronto Star
Koryx Copper Files Final Short Form Prospectus in Connection With $17.4 Million Bought Deal Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) — Koryx Copper Inc. ('Koryx' or the 'Company') (TSX-V: KRY) is pleased to announce that it has filed and been receipted for a final short form prospectus dated July 28, 2025 (the 'Prospectus') in connection with its previously announced 'bought deal' public offering of 16,563,200 common shares (the 'Offered Shares') of the Company at a price of C$1.05 per Offered Share (the 'Issue Price') for aggregate gross proceeds to the Company of C$17,391,360 (the 'Offering'), as further described in the news releases of the Company dated July 9 and 10, 2025. In addition, the Company also granted the Underwriters (as defined below) an option (the 'Over-Allotment Option'), exercisable in whole or in part at any time and from time to time for up to 30 days following closing date, to purchase up to an additional 2,484,480 at the Issue Price for additional gross proceeds of up to C$2,608,704. The Underwriters have exercised the Over-Allotment Option in full.
